Name
Natera, Inc.
Company Description
Signatera™ is a personalized, tumor-informed assay, optimized to detect circulating tumor DNA (ctDNA) for molecular residual disease (MRD) assessment and recurrence monitoring for patients previously diagnosed with cancer. Results are based on the unique signature of a patient’s tumor by tracking mutations at the source and enabling accurate monitoring of disease over time. Discover more at: natera.com/oncology
Website
Featured Exhibitor
Yes
Address (city, state, and country will display online and in-print)
San Carlos, CA
United States
United States
Contacts
Badges
